Virbac Group

VIRP:FP FR0000031577
Key Information
HQ:
France
Market Cap:
$4.08bn
Primary Market:
Europe & Russia



Company Information

Company Summary

Virbac S.A. is a pharmaceutical company producing animal food and medicine for veterinarians, breeders & owners to deal with animal pathology. It is dedicated exclusively to animal health. Virbac’s wide range of vaccines and medicines are used in the prevention and treatment of the main pathologies for both companion and food-producing animals.
Virbac

Animal Pharmaceuticals Engagement

Analysis Breakdown




Revenue, Sales and Marketing Practices

Strategy, risk and reporting on antibiotics
Low
Applying a consistent sales and marketing approach in line with best practice operating market
NRD



Manufacturing and Production

Demonstrating effective management of antibiotic residues in manufacturing and production
Low



Research and Development

Defining alternatives to antibiotics
Low
Increasing availability and use of alternatives to antibiotics
Low



Stewardship and Lobbying

Stewardship initiatives
NRD
Lobbying and political expenditure
NRD



Company Engagement

Level of company engagement with FAIRR and investor signatories
Partial

Members-only Content

To register as a member of the FAIRR network, please fill out the sign up form or if you need additional information on the FAIRR network, please contact investoroutreach@fairr.org.